Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT00862459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Diseases
Spinal Cord Diseases

Interventions

DRUG: Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)
DRUG: Gadobutrol~0.1 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)
DRUG: Gadobutrol~0.3 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)
DRUG: OptiMARK~0.1 mmol/kg BW

Sponsor

Bayer